MEDP

SEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 1

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001668397-24-000049 · wk-form4_1709760994.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 4,983,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.52 to $408.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000047 · wk-form4_1709760493.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,983,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.52 to $408.21. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000041 · wk-form4_1709328708.xml · nonDerivative · entry 2

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,341

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $399.7028 to $403.1386. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000043 · wk-form4_1709586674.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,033,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.88. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000045 · wk-form4_1709587916.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,033,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $404.88. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000041 · wk-form4_1709328708.xml · nonDerivative · entry 1

EWALD STEPHEN P · CIK 0001677297 · General Counsel & Corp. Secy.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,691

F1 · shares: Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person.

SEC source: 0001668397-24-000039 · wk-form4_1709328306.xml · nonDerivative · entry 1

GEIGER JESSE J · CIK 0001677399 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,824

F1 · shares: Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person.

SEC source: 0001668397-24-000043 · wk-form4_1709586674.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,113,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.41 to $401.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000045 · wk-form4_1709587916.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,113,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.41 to $401.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000035 · wk-form4_1709241398.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,133,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.105 to $407.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000033 · wk-form4_1709241090.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,133,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.105 to $407.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000037 · wk-form4_1709327813.xml · derivative · entry 3

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 472

Underlying: Common Stock · 500 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on May 14, 2020.

SEC source: 0001668397-24-000037 · wk-form4_1709327813.xml · nonDerivative · entry 2

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000037 · wk-form4_1709327813.xml · nonDerivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000035 · wk-form4_1709241398.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,183,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $398.84 to $404.17. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000033 · wk-form4_1709241090.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,183,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $398.84 to $404.17. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000027 · wk-form4_1709068610.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,233,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $397.98 to $405.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000025 · wk-form4_1709068117.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,233,019

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $397.98 to $405.72. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000031 · wk-form4_1709156065.xml · derivative · entry 4

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 972

Underlying: Common Stock · 500 shares

Expires 2026-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on May 14, 2020.

SEC source: 0001668397-24-000031 · wk-form4_1709156065.xml · nonDerivative · entry 3

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000031 · wk-form4_1709156065.xml · nonDerivative · entry 2

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000031 · wk-form4_1709156065.xml · nonDerivative · entry 1

Keating Ashley M. · CIK 0001777217 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0001668397-24-000027 · wk-form4_1709068610.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,289,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $396.15 to $402.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000025 · wk-form4_1709068117.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,289,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $396.15 to $402.50. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000023 · wk-form4_1708722912.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,389,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.86 to $401.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000021 · wk-form4_1708722670.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,389,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.86 to $401.45. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000023 · wk-form4_1708722912.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,489,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $379.96 to $386.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000021 · wk-form4_1708722670.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,489,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $379.96 to $386.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000017 · wk-form4_1708552196.xml · nonDerivative · entry 2

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,525,959

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $385.00 to $389.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000015 · wk-form4_1708551923.xml · nonDerivative · entry 2

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,525,959

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $385.00 to $389.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000019 · wk-form4_1708635948.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,782 shares

Expires 2024-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested in full on May 17, 2018.

SEC source: 0001668397-24-000019 · wk-form4_1708635948.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,595

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001668397-24-000017 · wk-form4_1708552196.xml · nonDerivative · entry 1

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,539,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.06 to $394.95. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0001668397-24-000015 · wk-form4_1708551923.xml · nonDerivative · entry 1

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,539,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.06 to $394.95. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001668397-24-000007 · wk-form4_1707771991.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,710 shares

Expires 2025-08-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option vested in full on May 16, 2019.

SEC source: 0001668397-24-000007 · wk-form4_1707771991.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,038

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000892251-24-000010 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 103 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 413 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

SEC source: 0000892251-24-000010 · form4.xml · nonDerivative · entry 1

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-24-000012 · form4.xml · derivative · entry 2

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 94 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 376 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

SEC source: 0000892251-24-000012 · form4.xml · nonDerivative · entry 1

Kraft Robert O. · CIK 0001558592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-24-000011 · form4.xml · derivative · entry 2

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 82 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

F2 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 328 restricted stock units, which vested in multiple tranches and was fully vested on December 31, 2023.

SEC source: 0000892251-24-000011 · form4.xml · nonDerivative · entry 1

McCarthy Cornelius P. III · CIK 0001750355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

SEC source: 0000892251-23-000201 · form4.xml · nonDerivative · entry 2

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,283

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

SEC source: 0000892251-23-000201 · form4.xml · nonDerivative · entry 1

BURWIG SUSAN E · CIK 0001677418 · Exec. VP, Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,292

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $303.00 to $305.455. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000195 · form4.xml · nonDerivative · entry 4

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,589,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F6 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000194 · form4.xml · nonDerivative · entry 4

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,589,947

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F5 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000195 · form4.xml · nonDerivative · entry 3

Troendle August J. · CIK 0001622058 · Director · CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Medpace Investors, LLC

Disclosed balance after: 5,613,986

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by Medpace Investors, LLC ("MPI") during an open window period.

F5 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $273.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

F3 · ownership.nature: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0000892251-23-000194 · form4.xml · nonDerivative · entry 3

Medpace Investors, LLC · CIK 0001524599 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,613,986

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

F4 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $273.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

SEC source: 0000892251-23-000196 · form4.xml · derivative · entry 2

Carley Brian T · CIK 0001677791 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313

Underlying: Common Stock · 313 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.

F2 · derivative.exercise_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.

F2 · derivative.expiration_date: The restricted stock units vest in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024, and December 31, 2024.